Search Immortality Topics:

Page 11«..10111213..2030..»

Biotechnology Research Review Market by Top Brands, Trends and Demand 2018 to 2023 – Fusion Science Academy

Posted: January 18, 2020 at 12:45 pm

In 2029, the Basmati Rice market is spectated to surpass ~US$ xx Mn/Bn with a CAGR of xx% over the forecast period. The Basmati Rice market clicked a value of ~US$ xx Mn/Bn in 2018. Region is expected to account for a significant market share, where the Basmati Rice market size is projected to inflate with a CAGR of xx% during the forecast period.

In the Basmati Rice market research study, 2018 is considered as the base year, and 2019-2029 is considered as the forecast period to predict the market size. Important regions emphasized in the report include region 1 (country 1, country2), region 2 (country 1, country2), and region 3 (country 1, country2).

Request Sample Report @

Global Basmati Rice market report on the basis of market players

The report examines each Basmati Rice market player according to its market share, production footprint, and growth rate. SWOT analysis of the players (strengths, weaknesses, opportunities and threats) has been covered in this report. Further, the Basmati Rice market study depicts the recent launches, agreements, R&D projects, and business strategies of the market players including

Companies Mentioned in the Report

McCormick & Co. Inc., LT Foods Ltd., The Hain Celestial Group Inc., Estraco Kft., East End Foods, The Rice n Spice Intl Ltd., KRBL Ltd., Amira Nature Foods Ltd., Mars Inc., and REI Agro Ltd. are the leading companies functional in the global market for basmati rice.

Report available at a discounted price exclusively!!! Offer ends today!!!

Request For Discount On This Report @

The Basmati Rice market report answers the following queries:

The Basmati Rice market report provides the below-mentioned information:

Buy This Report @

Research Methodology of Basmati Rice Market Report

The global Basmati Rice market study covers the estimation size of the market both in terms of value (Mn/Bn USD) and volume (x units). Both top-down and bottom-up approaches have been used to calculate and authenticate the market size of the Basmati Rice market, and predict the scenario of various sub-markets in the overall market. Primary and secondary research has been thoroughly performed to analyze the prominent players and their market share in the Basmati Rice market. Further, all the numbers, segmentation, and shares have been gathered using authentic primary and secondary sources.

Read this article:
Biotechnology Research Review Market by Top Brands, Trends and Demand 2018 to 2023 - Fusion Science Academy

Recommendation and review posted by G. Smith

Cuba’s revolutionary cancer vaccine builds bridges between the island and the United States – AL DIA News

Posted: January 18, 2020 at 12:45 pm

Despite the fact that Donald Trump's government is determined to continue sanctioning Cuba - the charter flights from the U.S. to nine Cuban airports were suspended last week because of the country's support for Maduro's regime, according to statements by Secretary of State Mike Pompeo - the collaboration between the United States and the island continues, at least on scientific matters. And this should not surprise us, taking into account the great medical advances made by Cuban professionals in the treatment of various types of cancer.

This is what we'll be able to witness in "Cuba's Cancer Hope," a documentary by Llew Smith that will be released next April by PBS and that sheds light on CimaVax, a revolutionary treatment against lung cancer that prolongs the life of patients in very advanced stages and that the Center of Molecular Immunology (CIM) in Habana has taken more than twenty years to develop.

In fact, the results are so encouraging that the Roswell Park Comprehensive Cancer Center in New York soon joined the project and will be the first U.S. institution to conduct a clinical trial of the drug produced on the island.

"The future of our country must necessarily be a future of men of science and thought, because that is precisely what we are sowing most," Fidel Castro, 1960.

Llew Smith himself was one of the volunteers to test this pioneering treatment, according to Prensa Latina, and his results, which were made known two years ago, will be part of the documentary.

"The wonderful thing about working with our Cuban colleagues is that they really believe, in their heart of hearts, that medical care is a human right," said Dr. Kevin Lee, director of the Roswell Park immunology department, in a dialogue with the press, praising the medical advances being made in Cuba and its "great potential to treat and prevent cancer of various kinds."

Cuba a pioneer in science

Biotechnology is one of the most developed branches of Cuban science, which began to be promoted in 1980, when Fidel Castro's government created a group dedicated to the production of interphenon, a possible cancer drug, in addition to promoting scientific parks.

This is a commitment to progress that the current president of Cuba, Miguel Daz-Canel Bermdez, acknowledged to Castro on the occasion of the documentary, and which the late revolutionary leader already advocated in a speech made in 1960when he said:

"The future of our country must necessarily be a future of men of science and thoughtbecause that is precisely what we are sowing most."

But the CimaVax is not the only discovery of Cuban scientists, whose achievements can be traced in the history of the island:

In 1881, the scientist Carlos Juan Finlay was the discoverer of the agent that transmits yellow fever, the Aedes aegypti mosquito, which made it possible to clean up the areas invaded by this infectious agent and which, in the end, has prevented millions of deaths.

"The wonderful thing about working with our Cuban colleagues is that they truly believe, deep in their hearts, that medical care is a human right," Dr. Kevin Lee from Roswell Park.

Also at Cuba's Center for Genetic Engineering and Biotechnology (CIGB), Heberprot-P was developed, a unique drug that prevents the amputation of diabetic feet by healing ulcers.

In addition, Cuba was recognized by WHO as the first country in the world to eliminate mother-to-child transmission of HIV.

The documentary "Cuba's Cancer Hope" also includes other therapies being experimented with on the island, specifically for the treatment of different types of cancer, which once again confirms thatscientific advances are breaking down the walls that apparently separate us.

Read the original here:
Cuba's revolutionary cancer vaccine builds bridges between the island and the United States - AL DIA News

Recommendation and review posted by G. Smith

Vir Biotechnology (NYSE:VIR) Reaches New 52-Week High at $16.60 – Riverton Roll

Posted: January 18, 2020 at 12:45 pm

Vir Biotechnology (NYSE:VIR) shares reached a new 52-week high on Thursday . The stock traded as high as $16.60 and last traded at $16.52, with a volume of 2924 shares changing hands. The stock had previously closed at $15.26.

A number of research analysts recently weighed in on the stock. Zacks Investment Research downgraded shares of Vir Biotechnology from a hold rating to a sell rating in a research report on Saturday, January 11th. Goldman Sachs Group began coverage on shares of Vir Biotechnology in a research report on Tuesday, November 5th. They issued a buy rating and a $37.00 target price for the company. Robert W. Baird began coverage on shares of Vir Biotechnology in a research note on Wednesday, November 13th. They set a neutral rating for the company. Cowen began coverage on Vir Biotechnology in a report on Tuesday, November 19th. They set a buy rating on the stock. Finally, JPMorgan Chase & Co. assumed coverage on Vir Biotechnology in a report on Tuesday, November 5th. They set an overweight rating and a $25.00 price target on the stock. One analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the company. Vir Biotechnology currently has a consensus rating of Buy and an average target price of $29.00.

The stock has a 50-day moving average price of $12.86.

Vir Biotechnology (NYSE:VIR) last released its quarterly earnings results on Tuesday, November 19th. The company reported ($4.60) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($3.71) by ($0.89). The firm had revenue of $1.40 million for the quarter.

About Vir Biotechnology (NYSE:VIR)

Vir Biotechnology, Inc, a clinical-stage immunology company, develops therapeutic products for the treatment and prevention of serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of human immunodeficiency virus, and VIR-2020 for the prevention of tuberculosis.

Read More: What is a Call Option?

Receive News & Ratings for Vir Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vir Biotechnology and related companies with's FREE daily email newsletter.

See the original post here:
Vir Biotechnology (NYSE:VIR) Reaches New 52-Week High at $16.60 - Riverton Roll

Recommendation and review posted by G. Smith

We Think Unity Biotechnology (NASDAQ:UBX) Needs To Drive Business Growth Carefully – Simply Wall St

Posted: January 18, 2020 at 12:45 pm

Even when a business is losing money, its possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business lost money for years while it grew recurring revenue, if you held shares since 2005, youd have done very well indeed. Having said that, unprofitable companies are risky because they could potentially burn through all their cash and become distressed.

So should Unity Biotechnology (NASDAQ:UBX) shareholders be worried about its cash burn? For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. Well start by comparing its cash burn with its cash reserves in order to calculate its cash runway.

See our latest analysis for Unity Biotechnology

A companys cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. Unity Biotechnology has such a small amount of debt that well set it aside, and focus on the US$113m in cash it held at September 2019. Importantly, its cash burn was US$71m over the trailing twelve months. That means it had a cash runway of around 19 months as of September 2019. While that cash runway isnt too concerning, sensible holders would be peering into the distance, and considering what happens if the company runs out of cash. The image below shows how its cash balance has been changing over the last few years.

Some investors might find it troubling that Unity Biotechnology is actually increasing its cash burn, which is up 25% in the last year. In light of that, the flat year on year operating leverage is a bit off-putting. In light of the data above, were fairly sanguine about the business growth trajectory. While the past is always worth studying, it is the future that matters most of all. For that reason, it makes a lot of sense to take a look at our analyst forecasts for the company.

Unity Biotechnology seems to be in a fairly good position, in terms of cash burn, but we still think its worthwhile considering how easily it could raise more money if it wanted to. Issuing new shares, or taking on debt, are the most common ways for a listed company to raise more money for its business. One of the main advantages held by publicly listed companies is that they can sell shares to investors to raise cash to fund growth. We can compare a companys cash burn to its market capitalisation to get a sense for how many new shares a company would have to issue to fund one years operations.

Unity Biotechnologys cash burn of US$71m is about 21% of its US$334m market capitalisation. Thats not insignificant, and if the company had to sell enough shares to fund another years growth at the current share price, youd likely witness fairly costly dilution.

Even though its increasing cash burn makes us a little nervous, we are compelled to mention that we thought Unity Biotechnologys cash runway was relatively promising. Even though we dont think it has a problem with its cash burn, the analysis weve done in this article does suggest that shareholders should give some careful thought to the potential cost of raising more money in the future. For us, its always important to consider risks around cash burn rates. But investors should look at a whole range of factors when researching a new stock. For example, it could be interesting to see how much the Unity Biotechnology CEO receives in total remuneration.

Of course Unity Biotechnology may not be the best stock to buy. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

If you spot an error that warrants correction, please contact the editor at This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.

Continue reading here:
We Think Unity Biotechnology (NASDAQ:UBX) Needs To Drive Business Growth Carefully - Simply Wall St

Recommendation and review posted by G. Smith

Global Marine Biotechnology Market 2019 by Company, Regions, Type and Application, Forecast to 2024 – Fusion Science Academy

Posted: January 18, 2020 at 12:44 pm

Transparency Market Research, in its latest market intelligence study, finds that the global Coulis market registered a value of ~US$ xx Mn/Bn in 2018 and is spectated to grow at CAGR of xx% during the foreseeable period 2019-2029. In terms of product type, segment holds the largest share, while segment 1 and segment 2 hold significant share in terms of end use.

The Coulis market study outlines the key regions Region 1 (Country 1, Country 2), region 2 (Country 1, Country 2), region 3 (Country 1, Country 2) and region 4 (Country 1, Country 2). All the consumption trends and adoption patterns of the Coulis are covered in the report. Prominent players, including player 1, player 2, player 3 and player 4, among others, account for substantial shares in the global Coulis market.

Request Sample Report @

Market Segmentation:

The global coulis market is segmented on the basis of source, distribution channel, end-user, and region. On the basis of source, the global coulis market is segmented as fruits and vegetables, wherein fruits segment have significant revenue share and is expected to have substantial growth rate, owing to rapidly growing demand for berries and food products made up of berries across the globe. Fruit segment further sub-segmented into raspberry, apricot, strawberry, blackberry, mango, and others. Among these, raspberry segment contribute for the lion share in the global coulis market. Vegetable segment is further sub-segmented as red pepper, cilantro, tomato, and others. On the basis of distribution channel, the global coulis market is segmented as wholesale and retail. Retail segment is fragmented into hypermarket/supermarket, convenience store, and e-Commerce. Among distribution channel segment, the wholesale segment is expected to have a substantial revenue share in coulis market, owing to significantly growing food service and manufacturing sector across the globe, whereas retail segment has the substantial growth rate. On the basis of end-use, the global coulis market is segmented as food services, consumers, and food product manufacturing wherein food services segment have significant revenue share, whereas consumers segment is expected to have substantial growth rate, owing to changing lifestyle and increasing per capita income of the consumers across the globe.

Based on source, the global coulis market is segmented into:

Based on distribution channel, the global coulis market is segmented into:

Based on end-use, the global coulis market is segmented into:

Global Coulis Market Regional Outlook:

Based on the geographies, the global coulis market is fragmented into seven regions North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific except Japan, Japan, and the Middle East & Africa. Among the regions, North America and Western Europe account for a relatively high share of the coulis market, attributed high demand for processed food across the region. The Asia-Pacific except Japan region also accounts for the significant share in the global coulis market with substantial growth rate, owing to the rapidly growing population, increasing per capita income, and changing lifestyle of the consumers across the region. Eastern Europe and Japan also accounts for significant value share in the global coulis market. The developing economy such as Middle East Africa and Latin America have a substantial growth in the global coulis market. Overall, the outlook for the global coulis market will have a positive growth over the forecast period, increasing food service industry, increasing per capita income, and rapid economic growth, being counterfeiting factors.

Global Coulis Market Player:

Few players in the global coulis market include SICA SICODIS, ITALIAN TASTE, Fuerst Day Lawson, FABRICA DE CONSERVE DIN CALARASI SA, Hiltfields Ltd., PATRELLE, Italia Foods, Inc., SPAIN JUICE TIMNAR, S.L., Fruitapeel, LES FRUITS ROUGES DE L'AISNE, Andrew Ingredients, and Lynch Foods.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

The regional analysis covers:

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industrys value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

Note:Although care has been taken to maintain the highest levels of accuracy in TMRs reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Request For Discount On This Report @

The Coulis market research answers important questions, including the following:

The Coulis market research serves a platter of the following information:

RequestTOC For ThisReport @

Why go for Transparency Market Research?

Transparency Market Research stays aligned with the fact the organization lands among the leading market research firms in India. Our analysts work irrespective of the time-zone, the result, we are being recognized worldwide. We abide by the notion that each client has his/her own set of requirements. With extensive primary and secondary research, our experts churn out the most accurate information regarding the desired the market.

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The companys exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMRs experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.


Mr. Rohit BhiseyTransparency Market ResearchState Tower90 State Street,Suite 700,Albany, NY 12207United StatesTel: +1-518-618-1030USA Canada Toll Free: 866-552-3453Email: [emailprotected]Website:

See the original post:
Global Marine Biotechnology Market 2019 by Company, Regions, Type and Application, Forecast to 2024 - Fusion Science Academy

Recommendation and review posted by G. Smith

Immortality or Scam? Russian Company Offers to Freeze Dead Brains to Revive Them in Future – News18

Posted: January 18, 2020 at 12:43 pm

Immortality has always been one of the biggest human obsessions. From fantasy to science fiction, eternal life is often depicted both a boon and a bane. And now, a Russian firm could be making these dreams of immortality real - for only Rs 25 lakh.

A Russian firm by the name of KrioRus is offering to freeze human brains and cadavers in cryogenic cylinders for the sum of Rs 25 lakh. the bodies will be frozen in liquid nitrogen for an unspecified time until the technology becomes available for reanimating the body again.

If it sounds like a nightmare out of Dr Frankenstein's head, you are probably not far off the mark.

When Alexei Voronenkovs 70-year-old mother passed away, he paid to have her brain frozen and stored in the hope breakthroughs in science will one day be able to bring her back to life.

It is one of 71 brains and human cadavers that KrioRus calls its patients - floating in liquid nitrogen in one of several metres-tall vats in a corrugated metal shed outside Moscow.

They are stored at -196 degrees Celsius (-320.8F) with the aim of protecting them against deterioration, although there is currently no evidence science will be able to revive the dead.

I did this because we were very close and I think it is the only chance for us to meet in the future, said Voronenkov who intends to undergo the procedure, known as cryonics, when he dies.

The head of the Russian Academy of Sciencess Pseudoscience Commission, Evgeny Alexandrov, described cryonics as an exclusively commercial undertaking that does not have any scientific basis, in comments to the Izvestia newspaper.

It is a fantasy speculating on peoples hopes of resurrection from the dead and dreams of eternal life, the newspaper quoted him as saying.

Valeriya Udalova, KrioRuss director who got her dog frozen when it died in 2008, said it is likely that humankind will develop the technology to revive dead people in the future, but that there is no guarantee of such technology.

KrioRus says hundreds of potential clients from nearly 20 countries have signed up for its after-death service.

It costs $36,000 (about Rs 25 lakh) for a whole body and $15,000 (about Rs 10 lakh) for the brain alone for Russians, who earn average monthly salaries of $760, according to official statistics. Prices are slightly higher for non-Russians.

The company says it is the only one in Russia and the surrounding region. Set up in 2005, it has at least two competitors in the United States, where the practice dates back further.

Voronenkov said he set his hopes on science. I hope one day it reaches a level when we can produce artificial bodies and organs to create an artificial body where my mothers brain can be integrated.

KrioRus director Udalova argues that those paying to have dying relatives remains preserved are showing how much they love them.

They try to bring hope, she said. What can we do for our dying relatives or the ones that we love? A nice burial, a photo album, she said. They go further, proving their love even more.

(With inputs from Reuters)

Get the best of News18 delivered to your inbox - subscribe to News18 Daybreak. Follow on Twitter, Instagram, Facebook, Telegram, TikTok and on YouTube, and stay in the know with what's happening in the world around you in real time.

Read the original here:
Immortality or Scam? Russian Company Offers to Freeze Dead Brains to Revive Them in Future - News18

Recommendation and review posted by G. Smith

Page 11«..10111213..2030..»